Timing Of Endoscopic Retrograde Cholangiopancreatography (ERCP) In Patients With Acute Gallstone Pancreatitis During The First Wave Of Covid-19 Pandemic, Are We Following The Guidelines!

 

Aims: Introduction Gallstone is well known, among other aetiologies, cause of Acute pancreatitis¹. It is crucial to make early diagnosis as different treatment approached is recommended which includes early ERCP and cholecystectomy². In a proven or suspected gallstone pancreatitis, patients should undergo a therapeutic ERCP within 72 hours as per BSG guidleines³.

Methods We retrospectively studied all ERCP procedures done during the first wave of Covid-19 between Jan-Jun 2020. Data were retrieved using electronic patient records as well as endoscopic reporting applications.

Results 113 ERCP had been performed in our hospital during the first wave of Covid-19. Among them, they was only 8 patients who had ERCP for Acute Gallstone Pancreatitis. 5 patients only had ERCP during the 72 hours of the onset of pain occurred in 60 % (n = 3). 2 patients did not have their ERCP within the recommended time and one patient received medical treatment.

Conclusions 60 % adherence is not adequate. We recommend development of local stander of procedure, pathway, or enhancement of early referral to Endoscopy unit. We recommend that all referral to ERCP will need to be reviewed with more urgency. Feedback to the acute medical team and emergency department to make more urgent referral to hepatobiliary team when gallstone pancreatitis is suspected.

Citation Gadour E, Musharaf M, Hafeez S et al. eP344 TIMING OF ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY (ERCP) IN PATIENTS WITH ACUTE GALLSTONE PANCREATITIS DURING THE FIRST WAVE OF COVID-19 PANDEMIC, ARE WE FOLLOWING THE GUIDELINES! Endoscopy 2021; 53: S209.

Publication History

Article published online:
19 March 2021

© 2021. European Society of Gastrointestinal Endoscopy. All rights reserved.

Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany